Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

26 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
PAX5::AUTS2 childhood B-ALL: a relapse-prone genetic subtype with frequent central nervous system involvement and a poor outcome.
Caye-Eude A, Fazio G, Pastorczak A, Boer JM, Steinemann D, Ganguli D, Sonneveld E, Haslinger S, D'Andrea L, Bradtke J, Lopes BA, Zaliova M, Escherich G, König M, Fortschegger K, Inthal A, Stasevich I, Emerenciano M, Trka J, Castillo L, Parihar M, Moorman AV, Bergmann AK, den Boer ML, Młynarski W, Cazzaniga G, Cavé H, Nebral K, Schinnerl D, Strehl S. Caye-Eude A, et al. Leukemia. 2024 Dec 19. doi: 10.1038/s41375-024-02502-5. Online ahead of print. Leukemia. 2024. PMID: 39702796 No abstract available.
[Update on acute leukemia of ambiguous lineage in 2023 - Recommendations of the French Society for Childhood and Adolescent Cancer and Leukemia (SFCE)].
Simonin M, Lainey E, Rialland F, Caye-Eude A, Reguerre Y, Boutroux H, Azarnoush S, Thouvenin S, Rohrlich PS, Baruchel A. Simonin M, et al. Among authors: caye eude a. Bull Cancer. 2023 Oct 27:S0007-4551(23)00383-1. doi: 10.1016/j.bulcan.2023.09.004. Online ahead of print. Bull Cancer. 2023. PMID: 39492072 Review. French.
CD36 cell surface expression as a surrogate marker to identify ABL/JAK-class kinase fusions in pediatric BCP-ALL.
Strullu M, Caye-Eude A, Robert E, Renard JM, Chaye A, Galimand J, Fenneteau O, Arfeuille C, Cuccuini W, Theron A, Thouvenin S, Paillard C, Petit A, Rohrlich PS, Cavé H, Baruchel A, Lainey E. Strullu M, et al. Among authors: caye eude a. Leukemia. 2024 Oct 17. doi: 10.1038/s41375-024-02421-5. Online ahead of print. Leukemia. 2024. PMID: 39420220
Outcomes of infants with very late relapse of acute lymphoblastic leukaemia initially treated in Interfant-06.
Lecornec N, Fahd M, De Lorenzo P, Valsecchi MG, Micalizzi C, Diaz P, Pennella C, Locatelli F, Vinti L, Cavé H, Caye-Eude A, Stary J, Pieters R, Baruchel A, Brethon B. Lecornec N, et al. Among authors: caye eude a. Br J Haematol. 2024 Sep;205(3):1230-1233. doi: 10.1111/bjh.19634. Epub 2024 Jul 9. Br J Haematol. 2024. PMID: 38982637 No abstract available.
Success of donor-derived CAR-T cells after failure of autologous CD19 CAR-T cells (tisagenlecleucel) in B-cell acute lymphoblastic leukaemia.
Dourthe ME, Yakouben K, David A, Thouvenin S, Chaillou D, Caillat-Zucman S, Cuffel A, Tardy C, Lainey E, Caye-Eude A, Arfeuille C, Delaugerre C, Chaix-Baudier ML, Naudin J, Auvin S, Bergaoui K, Merlat-Guitard AI, De Jorna R, Mebarki M, Dalle JH, Baruchel A. Dourthe ME, et al. Among authors: caye eude a. Br J Haematol. 2024 Jul;205(1):373-377. doi: 10.1111/bjh.19524. Epub 2024 May 12. Br J Haematol. 2024. PMID: 38735758 No abstract available.
Differential activation of basal and IL-7-induced PI3K/Akt/ mTOR and JAK/STAT5 signaling distinguishes pediatric from adult acute lymphoblastic leukemia.
Fernandes MB, Gomes AM, Oliveira ML, Caldas J, Lúcio P, Kim R, Caye-Eude A, Pereira F, De Sousa AB, De Stefano A, Follo MY, Soares MV, Lacerda JF, Desterro J, Cavé H, Clappier E, Duarte X, Ribeiro P, Barata JT. Fernandes MB, et al. Among authors: caye eude a. Haematologica. 2024 Aug 1;109(8):2671-2675. doi: 10.3324/haematol.2023.284102. Haematologica. 2024. PMID: 38654666 Free PMC article. No abstract available.
A predictive classifier of poor prognosis in transplanted patients with juvenile myelomonocytic leukemia: a study on behalf of the Société Francophone de Greffe de Moelle et de Thérapie Cellulaire.
Meyran D, Arfeuille C, Chevret S, Neven Q, Caye-Eude A, Lainey E, Petit A, Rialland F, Michel G, Plantaz D, Jubert C, Theron A, Gandemer V, Ouachée-Chardin M, Paillard C, Bruno B, Buchbinder N, Pochon C, Calvo C, Fahd M, Baruchel A, Cavé H, Dalle JH, Strullu M. Meyran D, et al. Among authors: caye eude a. Haematologica. 2024 Sep 1;109(9):2908-2919. doi: 10.3324/haematol.2023.284103. Haematologica. 2024. PMID: 38385260 Free PMC article.
Germline bi-allelic SH2B3/LNK alteration predisposes to a neonatal juvenile myelomonocytic leukemia-like disorder.
Arfeuille C, Vial Y, Cadenet M, Caye-Eude A, Fenneteau O, Neven Q, Bonnard AA, Pizzi S, Carpentieri G, Capri Y, Girardi K, Pedace L, Macchiaiolo M, Boudhar K, Khaled MB, Chahla WA, Lutun A, Fahd M, Drunat S, Flex E, Dalle JH, Strullu M, Locatelli F, Tartaglia M, Cavé H. Arfeuille C, et al. Among authors: caye eude a. Haematologica. 2024 Aug 1;109(8):2542-2554. doi: 10.3324/haematol.2023.283917. Haematologica. 2024. PMID: 37981895 Free PMC article.
Genetic alterations and MRD refine risk assessment for KMT2A-rearranged B-cell precursor ALL in adults: a GRAALL study.
Kim R, Bergugnat H, Pastoret C, Pasquier F, Raffoux E, Larcher L, Passet M, Grardel N, Delabesse E, Kubetzko S, Caye-Eude A, Meyer C, Marschalek R, Lafage-Pochitaloff M, Thiebaut-Bertrand A, Balsat M, Escoffre-Barbe M, Blum S, Baumann M, Banos A, Straetmans N, Gallego-Hernanz MP, Chalandon Y, Graux C, Soulier J, Leguay T, Hunault M, Huguet F, Lhéritier V, Dombret H, Boissel N, Clappier E. Kim R, et al. Among authors: caye eude a. Blood. 2023 Nov 23;142(21):1806-1817. doi: 10.1182/blood.2023021501. Blood. 2023. PMID: 37595275 Free article.
26 results